Literature DB >> 20594110

Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program.

Thomas G Fraser1, Cynthia Fatica, Michele Scarpelli, Alejandro C Arroliga, Jorge Guzman, Nabin K Shrestha, Eric Hixson, Miriam Rosenblatt, Steven M Gordon, Gary W Procop.   

Abstract

OBJECTIVE: To evaluate the effects of an active surveillance program for Staphylococcus aureus linked to a decolonization protocol on the incidence of healthcare-associated infection and new nasal colonization due to S. aureus.
DESIGN: Retrospective quasi-experimental study.
SETTING: An 18-bed medical intensive care unit at a tertiary care center in Cleveland, Ohio.
METHODS: From January 1, 2006, through December 31, 2007, all patients in the medical intensive care unit were screened for S. aureus nasal carriage at admission and weekly thereafter. During the preintervention period, January 1 through September 30, 2006, only surveillance occurred. During the intervention period, January 1 through December 31, 2007, S. aureus carriers received mupirocin intranasally. Beginning in February 2007, carriers also received chlorhexidine gluconate baths.
RESULTS: During the preintervention period, 604 (73.7%) of 819 patients were screened for S. aureus nasal carriage, yielding 248 prevalent carriers (30.3%). During the intervention period, 752 (78.3%) of 960 patients were screened, yielding 276 carriers (28.8%). The incidence of S. aureus carriage decreased from 25 cases in 3,982 patient-days (6.28 cases per 1,000 patient-days) before intervention to 18 cases in 5,415 patient-days (3.32 cases per 1,000 patient-days) (P=.04; relative risk [RR], 0.53 [95% confidence interval {CI}, 0.28-0.97]) and from 9.57 to 4.77 cases per 1,000 at-risk patient-days (P=.02; RR, 0.50 [95% CI, 0.27-0.91]). The incidence of S. aureus hospital-acquired bloodstream infection during the 2 periods was 2.01 and 1.11 cases per 1,000 patient-days, respectively (P=.28). The incidence of S. aureus ventilator-associated pneumonia decreased from 1.51 to 0.18 cases per 1,000 patient-days (P=.03; RR, 0.12 [95% CI, 0.01-0.83]). The total incidence of S. aureus hospital-acquired infection decreased from 3.52 to 1.29 cases per 1,000 patient-days (P=.03; RR, 0.37 [95% CI, 0.14-0.90]).
CONCLUSIONS: Active surveillance for S. aureus nasal carriage combined with decolonization was associated with a decreased incidence of S. aureus colonization and hospital-acquired infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594110     DOI: 10.1086/654001

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis.

Authors:  Wensen Chen; Songqin Li; Lianhong Li; Xin Wu; Weihong Zhang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Impact of daily bathing with chlorhexidine gluconate on ventilator associated pneumonia in intensive care units: a meta-analysis.

Authors:  Wensen Chen; Quan Cao; Songqin Li; Huifen Li; Weihong Zhang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.

Authors:  Courtney A Gidengil; Charlene Gay; Susan S Huang; Richard Platt; Deborah Yokoe; Grace M Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

4.  Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection.

Authors:  Melissa A Viray; James C Morley; Craig M Coopersmith; Marin H Kollef; Victoria J Fraser; David K Warren
Journal:  Infect Control Hosp Epidemiol       Date:  2014-01-24       Impact factor: 3.254

5.  Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit.

Authors:  V O Popoola; A M Milstone
Journal:  J Perinatol       Date:  2014-07-10       Impact factor: 2.521

Review 6.  Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review.

Authors:  Lennie P G Derde; Mirjam J D Dautzenberg; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

7.  Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.

Authors:  Susan S Huang; Rupak Datta; Sheryl Rifas-Shiman; Ken Kleinman; Hilary Placzek; Julie D Lankiewicz; Richard Platt
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

8.  Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit.

Authors:  Yuarn-Jang Lee; Jen-Zon Chen; Hsiu-Chen Lin; Hsin-Yi Liu; Shyr-Yi Lin; Hsien-Ho Lin; Chi-Tai Fang; Po-Ren Hsueh
Journal:  Crit Care       Date:  2015-04-08       Impact factor: 9.097

9.  Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice.

Authors:  Manli Na; Wanzhong Wang; Ying Fei; Elisabet Josefsson; Abukar Ali; Tao Jin
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

Review 10.  The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis.

Authors:  Laura J Shallcross; Ellen Fragaszy; Anne M Johnson; Andrew C Hayward
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.